A pharmaceutical database has compiled and published basic information on Mometasone furoate cream 0.1% “Iwaki.” It outlines its indications, the main contents of the package insert, and an overview of its contraindications and adverse effects.
The basic information describes it as a drug that relieves eczema, itching and redness through its anti-inflammatory and immunosuppressive effects. It also states that the usual application method is to apply an appropriate amount to the affected area once daily or more frequently as needed.
The package insert reportedly lists the active ingredient, the range of indicated diseases, and representative adverse effects including increased intraocular pressure, contact dermatitis and skin infections.
As contraindications, use is to be avoided in patients with bacterial, fungal or viral infections or a history of hypersensitivity. Precautions for use reportedly include, in principle, avoiding use for eczematous inflammation accompanied by a skin infection.
The precautions state that extensive use of large amounts over a prolonged period should be avoided. The package insert also reportedly sets out points to consider for patients with specific characteristics, including pregnant women, breastfeeding women and older adults.